MCL @Work: Wendy Sempf - Insights
Wendy is a clinical laboratory technologist who works in the Hematopathology Morphology Laboratory at Mayo Clinic Laboratories. Although she’s worked with Mayo Clinic since 1989, her greatest passion is serving others throughout the...
Northeast winter storm - Insights
A winter storm is occurring in the Northeast which may impact specimen transport. The winter storm is expected to spread snow, strong winds, and create possible blizzard conditions which could impact courier pickups and route delays. We are...
Mayo Clinic Labs @Work: Kimberly Knight - Insights
As a national accounts executive for Mayo Clinic Laboratories, Kimberly Knight helps clients see and understand the importance of laboratory testing and how partnering with Mayo Clinic Laboratories on that testing can help them and their...
Mayo Clinic Labs @Work: Callie Bishop - Insights
As a director of operations for Mayo Clinic Laboratories, Callie Bishop helps meet the needs of Mayo Clinic Laboratories clients both virtually and onsite in the field.
Mayo Clinic Labs @Work: Vanessa Gonzalez Casar - Insights
As a hospital account executive for Mayo Clinic Laboratories, Vanessa Gonzalez Casar supports and partners with local hospitals to ensure their patients receive the right test at the right time.
Mayo Clinic Labs @Work: Sherri Hawkins - Insights
With nearly 30 years at Mayo Clinic, Sherri Hawkins has served in a wide range of laboratory-related roles. Beginning as a laboratorian on the bench and now serving as Group Purchasing Organization (GPO) manager, Sherri has been able to...
In this month's "Hot Topic," Brad Karon, M.D., Ph.D., reviews pediatric venipuncture volumes in this year’s Phlebotomy Top Gun case-based presentation as requested by previous Phlebotomy conference attendees.
Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D. - Insights
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal...
Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence, to discuss liquid biopsy...
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph.D., CEO and co-founder of Amprion. They discuss their strategic collaboration and...